The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital ...

Global bioprocess technology market will reach $88.39 billion by 2033, growing by 13.8% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use ...

Flow Cytometry MarketThe global flow cytometry market is on the cusp of a remarkable transformation, with projections indicating a substantial surge in market value over the next decade. According to ...

Flow chemistry is the development and study of chemical reactions whereby reactants are combined by pumping fluids, including solutions of reagents, through tubes at known rates. The relative ...

announced a framework collaboration agreement to enable and facilitate robotic arm integration with BD flow cytometry instruments to accelerate drug discovery and development. Together, the companies ...

to enable and facilitate robotic arm integration with BD flow cytometry instruments. This partnership aims to enhance the precision and efficiency of drug discovery and development processes ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm ...